Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique.

Mark Bloomston1, Atul Bhardwaj, E Christopher Ellison

  • 1Department of Pathology, The Ohio State University, Columbus, Ohio, USA.

Digestive Surgery
|May 24, 2006
PubMed
Summary

Epidermal growth factor receptor (EGFR) is overexpressed in most pancreatic cancers. While not predicting survival, EGFR expression may identify patients for targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversity in operative coaching: exploring gender and race differences in evaluations.

Surgical endoscopy·2026
Same author

Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma.

Communications medicine·2025
Same author

Lessons for the surgeon from the early history of the Zollinger Ellison syndrome: The 6th Alexander Walt Historical Lecture Presented at the Midwest Surgical Association 68th Annual Meeting Delavan, Wisconsin July 27, 2025.

American journal of surgery·2025
Same author

Lifetime stressor exposure and depression among patients with pancreatic cancer: insights from the Florida Pancreas Collaborative.

BMC cancer·2025
Same author

Endoscopic Ultrasound-guided Esophagojejunal Anastomosis for Delayed Reconstruction: A Case Series on the Novel Technique and our Experience.

Journal of gastrointestinal and liver diseases : JGLD·2025
Same author

Exploring the role of quality of life in surgical decision making for patients undergoing pancreatectomy.

American journal of surgery·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • The role of epidermal growth factor receptor (EGFR) overexpression in pancreatic carcinoma remains unclear.
  • Investigating EGFR expression is crucial for understanding pancreatic cancer progression and potential therapeutic targets.

Purpose of the Study:

  • To evaluate EGFR expression in pancreatic cancer.
  • To determine the association between EGFR expression, histopathologic characteristics, and patient survival.

Main Methods:

  • Utilized tissue microarrays from 71 pancreatic adenocarcinoma and 18 chronic pancreatitis cases.
  • Assessed EGFR expression via immunohistochemistry, determining staining intensity and percentage of positive tumor cells.
  • Defined positive EGFR expression as at least 1% membranous staining with 1+ intensity.

Related Experiment Videos

Main Results:

  • EGFR was overexpressed in 69% of pancreatic adenocarcinomas versus 39% of chronic pancreatitis cases (p=0.03).
  • No significant correlation was found between EGFR expression levels and tumor grade, size, or lymph node status.
  • Median survival was longer in EGFR-expressing tumors (15.2 months) compared to EGFR-negative tumors (8.3 months), but this difference was not statistically significant.

Conclusions:

  • EGFR is frequently overexpressed in pancreatic cancer, independent of histopathologic features.
  • EGFR expression does not appear to be a significant predictor of patient survival in pancreatic cancer.
  • Immunohistochemical analysis of EGFR can aid in identifying patients who may benefit from EGFR inhibitor therapies.